Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (321-330 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Antimicrobial Chemotherapy|December 4, 2020
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Helio S Sader, Cecilia G Carvalhaes, S J Ryan Arends, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2022
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 14, 2018
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin AmericaHelio S Sader, Robert K Flamm, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|February 28, 2016
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patientsRobert K Flamm, Wright W Nichols, Helio S Sader, et al.
Journal of Clinical Microbiology|May 29, 2015
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of TelavancinRodrigo E Mendes, David J Farrell, Robert K Flamm, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 13, 2020
Antimicrobial Activity of Telavancin Tested <i>In Vitro</i> Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017)Leonard R Duncan, Helio S Sader, Michael D Huband, et al.
Journal of Chemotherapy (Florence, Italy)|June 11, 2015
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancinRodrigo E Mendes, Robert K Flamm, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2021
Characterization of a vga gene variant recovered from a Staphylococcus saprophyticus causing a community-acquired urinary tract infection: report from the SENTRY Antimicrobial Surveillance Program 2017Lalitagauri Deshpande, Laura Cantrell, José R Romero, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 3, 2004
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001Helio S Sader, Ronald N Jones, Ana C Gales, et al.
Journal of Clinical Microbiology|July 11, 2006
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance programRonald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Pageof 42

Showing results (321-330 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|December 4, 2020
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Helio S Sader, Cecilia G Carvalhaes, S J Ryan Arends, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2022
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 14, 2018
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin AmericaHelio S Sader, Robert K Flamm, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents|February 28, 2016
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patientsRobert K Flamm, Wright W Nichols, Helio S Sader, et al.
Journal of Clinical Microbiology|May 29, 2015
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of TelavancinRodrigo E Mendes, David J Farrell, Robert K Flamm, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 13, 2020
Antimicrobial Activity of Telavancin Tested <i>In Vitro</i> Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017)Leonard R Duncan, Helio S Sader, Michael D Huband, et al.
Journal of Chemotherapy (Florence, Italy)|June 11, 2015
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancinRodrigo E Mendes, Robert K Flamm, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2021
Characterization of a vga gene variant recovered from a Staphylococcus saprophyticus causing a community-acquired urinary tract infection: report from the SENTRY Antimicrobial Surveillance Program 2017Lalitagauri Deshpande, Laura Cantrell, José R Romero, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 3, 2004
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001Helio S Sader, Ronald N Jones, Ana C Gales, et al.
Journal of Clinical Microbiology|July 11, 2006
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance programRonald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Pageof 42